Thai PBS Thai PBS
Thailand signs ฿500m deal to buy 50,000 courses of Molnupiravir COVID-19 medication

Thailand signs ฿500m deal to buy 50,000 courses of Molnupiravir COVID-19 medication

13 Sept 16:25 Key points summarised by AI
  • Thailand's Medical Services Department signed a ฿500 million deal with MSD (Thailand) to acquire 50,000 courses of Merck’s Molnupiravir oral anti-viral medication.
  • This new medication will treat COVID-19 infections, particularly for patients with moderate to severe symptoms and those at high risk, supplementing current treatments like Favipiravir.
  • Molnupiravir has shown efficacy in clinical trials, potentially reducing hospitalization by half, and is currently awaiting emergency use approval from both the US and Thai Food and Drug Administrations.
Read full article
Thai PBS World 1/1
Skip > Skip >